Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

India Globalization Capital Inc (IGC)

India Globalization Capital Inc (IGC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,006
  • Shares Outstanding, K 41,186
  • Annual Sales, $ 4,070 K
  • Annual Income, $ -7,320 K
  • 60-Month Beta 2.70
  • Price/Sales 7.13
  • Price/Cash Flow N/A
  • Price/Book 1.04
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.16
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5200 +22.96%
on 07/15/20
0.8300 -22.96%
on 07/28/20
+0.0624 (+10.81%)
since 07/10/20
3-Month
0.4500 +42.09%
on 05/14/20
0.8300 -22.96%
on 07/28/20
+0.1355 (+26.89%)
since 05/11/20
52-Week
0.2630 +143.12%
on 03/18/20
1.3100 -51.19%
on 09/19/19
-0.4906 (-43.42%)
since 08/09/19

Most Recent Stories

More News
FDA Approves Initiation of IGC's Cannabinoid Trial on Alzheimer's Patients

India Globalization Capital ("IGC" or the "Company") (NYSE American: IGC) announced today that on July 30, 2020, the U.S. Food and Drug Administration (FDA) notified IGC that it has authorized the Company...

IGC : 0.6394 (-5.97%)
IGC Receives a Notice of Allowance from the U.S. Patent Office

India Globalization Capital, Inc. (the "Company") (NYSE American: IGC) recently received a Notice of Allowance dated July 8, 2020 from the United States Patent and Trademark Office ("USPTO") for the Company's...

IGC : 0.6394 (-5.97%)
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2020

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the Fiscal Year Ended March 31, 2020.

IGC : 0.6394 (-5.97%)
India Globalization Capital, Inc. Announces Proposed Settlement of Three Derivative Lawsuits and Provides Notice to Shareholders

India Globalization Capital, Inc. (the "Company") (NYSE: IGC) announces today the proposed settlement of three derivative lawsuits pending since 2018 and 2019 and provides notice to shareholders of the...

IGC : 0.6394 (-5.97%)
IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals

India Globalization Capital, Inc. (the "Company") (NYSE: IGC) recently received notification that on March 24, 2020, the United States Patent and Trademark Office ("USPTO") issued a method and composition...

IGC : 0.6394 (-5.97%)
IGC Reports Financial Results for the Quarter Ended December 31, 2019

India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended December 31, 2019, which is the third quarter of its 2020 fiscal year.

IGC : 0.6394 (-5.97%)
IGC Reports Financial Results for the Quarter Ended September 30, 2019

India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended September 30, 2019, which is the second quarter of its 2020 fiscal year.

IGC : 0.6394 (-5.97%)
IGC Opens Marketing and Research Hub in Colombia

India Globalization Capital, Inc. (NYSE: IGC) announced today that it has opened a marketing and research office in Colombia, South America. Hamsa Biochem SAS, a new beneficially owned subsidiary of IGC,...

IGC : 0.6394 (-5.97%)
IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study

India Globalization Capital, Inc. (NYSE: IGC) announced today that the Institutional Review Board ("IRB"), in Puerto Rico, approved its protocol for a double-blind, placebo-controlled, efficacy, safety...

IGC : 0.6394 (-5.97%)
IGC Reports Financial Results for the Quarter Ended June 30, 2019

India Globalization Capital, Inc. (NYSE American: IGC) today announced its financial results for the quarter ended June 30, 2019, which is the first quarter of its 2020 fiscal year.

IGC : 0.6394 (-5.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade IGC with:

Business Summary

India Globalization Capital, Inc. is engaged in developing phytocannabinoid-based therapies. The company's patent filing for the indications of pain, medical refractory epilepsy and cachexia using phytocannabinoids. It also engage in leasing, trading, developing and managing infrastructure and real estate...

See More

Key Turning Points

2nd Resistance Point 0.7105
1st Resistance Point 0.6749
Last Price 0.6394
1st Support Level 0.6189
2nd Support Level 0.5985

See More

52-Week High 1.3100
Fibonacci 61.8% 0.9100
Fibonacci 50% 0.7865
Fibonacci 38.2% 0.6630
Last Price 0.6394
52-Week Low 0.2630

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar